These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1957207)

  • 21. [Present aspects of bone marrow lesions due to drugs (author's transl)].
    Hausmann K; Skrandies G; Sachtleben P
    MMW Munch Med Wochenschr; 1974 Sep; 116(38):1621-6. PubMed ID: 4215965
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs and the bone marrow.
    Treleaven J; Barrett J
    Br J Hosp Med; 1990 Oct; 44(4):245-50. PubMed ID: 2249099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow aplasia--a rare complication of imatinib therapy in CML patients.
    Srinivas U; Pillai LS; Kumar R; Pati HP; Saxena R
    Am J Hematol; 2007 Apr; 82(4):314-6. PubMed ID: 17013815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia.
    Wodnar-Filipowicz A; Lyman SD; Gratwohl A; Tichelli A; Speck B; Nissen C
    Blood; 1996 Dec; 88(12):4493-9. PubMed ID: 8977241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of aplastic anemia.
    Gale RP
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736
    [No Abstract]   [Full Text] [Related]  

  • 26. [The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis].
    Klimova NF; Cherntsova TA; Protasova TG
    Sov Med; 1967 Dec; 30(12):67-71. PubMed ID: 5250006
    [No Abstract]   [Full Text] [Related]  

  • 27. Complications in patients on therapeutic drugs.
    Petersen JK
    Int Dent J; 1986 Jun; 36(2):83-6. PubMed ID: 2941378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aplastic anemia in carbamazepine therapy].
    Betticher DC; Wolfisberg HP; Krapf R
    Schweiz Med Wochenschr; 1991 Apr; 121(16):583-8. PubMed ID: 2042043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppression as initial treatment for gold induced aplastic anemia.
    Mant MJ; Russell AS; Percy JS; Davis P; Messner HA
    J Rheumatol; 1987 Oct; 14(5):1026-9. PubMed ID: 3123673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study of ciclosporin in patients with aplastic anemia and pure red-cell aplasia].
    Kitamura K; Urabe A; Nomura T; Mizoguchi H; Takaku F
    Rinsho Ketsueki; 1995 Mar; 36(3):175-84. PubMed ID: 7783321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bone marrow aplasia associated with ticlopidine treatment in a patient with idiopathic hypothyroidism].
    Pioda GB; Del Favero A; Rambotti P
    Clin Ter; 1989 Sep; 130(6):337-40. PubMed ID: 2530035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of antilymphocyte and antithymocyte globulins for patients with severe aplastic anemia and pure red cell aplasia--analysis of immunologic parameters of peripheral lymphocytes concerning ALG and ATG therapy].
    Kawauchi K; Sugiyama H; Watanabe H; Urabe A; Takaku F
    Rinsho Ketsueki; 1990 Jan; 31(1):10-5. PubMed ID: 2107342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug accidents. Erythema multiforme and medullary aplasia].
    Dubiau JM
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(1):64-5. PubMed ID: 5565936
    [No Abstract]   [Full Text] [Related]  

  • 34. [Severe aplastic anemia as a complication of treatment with metizol].
    Swider G; Grzywa M; Zuzak Z
    Wiad Lek; 1996; 49(7-12):136-9. PubMed ID: 9245107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycemic coma, jaundice, and pure RBC aplasia following chlorpropamide therapy.
    Gill MJ; Ratliff DA; Harding LK
    Arch Intern Med; 1980 May; 140(5):714-5. PubMed ID: 7396601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marrow aplasia following topical application of chloramphenicol eye ointment.
    Abrams SM; Degnan TJ; Vinciguerra V
    Arch Intern Med; 1980 Apr; 140(4):576-7. PubMed ID: 7362398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pure red-cell aplasia associated with cotrimoxazole].
    Serrate San Miguel G; Franco Comet P; Puigbó Casañé MD; Font Creus B
    Med Clin (Barc); 1985 Mar; 84(8):334. PubMed ID: 3872389
    [No Abstract]   [Full Text] [Related]  

  • 38. Pure red cell aplasia associated with administration of sustained-release procainamide.
    Giannone L; Kugler JW; Krantz SB
    Arch Intern Med; 1987 Jun; 147(6):1179-80. PubMed ID: 3036033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.
    Cervetti G; Carulli G; Galimberti S; Azzarà A; Buda G; Orciuolo E; Pelosini M; Petrini M
    Leuk Res; 2008 Jan; 32(1):194-5. PubMed ID: 17459473
    [No Abstract]   [Full Text] [Related]  

  • 40. [Methimazole-induced aplastic anemia].
    Mechelli S; Bolognesi S; Siuti E; Stefanelli A; Castiglioni MG
    Recenti Prog Med; 1999 Sep; 90(9):470-2. PubMed ID: 10544668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.